Current and Future Perspectives on Clinical Management of Classic 21-Hydroxylase Deficiency
January 2023
in “
Endocrine Journal
”
Studysummary This review discusses the challenges in optimizing glucocorticoid treatment for classic 21-hydroxylase deficiency, emphasizing individualized care and the need for comprehensive management, but presents no new findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jstage.jst.go.jp →